Scribe Biosciences is Biotechnology in United States that focus on developer business. Founded in 2017. They cover business area such as developer, single-cell analysis tool, development, clinical and research application, droplet microfluidic, picoliter-scale manipulation, fluorescence-activate microfluidic droplet sorting, doctor, knowledge, study, process, infectious cancer disease.
2017
( 7 years old in 2024 )
Developer
-
953 Indiana Street
San Francisco, CA 94107
United States
Private
developersingle-cell analysis tooldevelopmentclinical and research applicationdroplet microfluidicpicoliter-scale manipulationfluorescence-activate microfluidic droplet sortingdoctorknowledgestudyprocessinfectious cancer disease
* We use standard office opening hours in near Scribe Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Scribe Biosciences is Biotechnology business from United States that founded in 2017 (7 years old in 2024), Scribe Biosciences business is focusing on Developer.
Scribe Biosciences headquarter office and corporate office address is located in 953 Indiana Street San Francisco, CA 94107 United States.
Scribe Biosciences was founded in United States.
In 2024, Scribe Biosciences is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Scribe Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
